Loading...
Dernières publications
-
Medhi Hassani, Dylan Moutachi, Mégane Lemaitre, Alexis Boulinguiez, Denis Furling, et al.. Beneficial effects of resistance training on both mild and severe mouse dystrophic muscle function as a preclinical option for Duchenne muscular dystrophy. PLoS ONE, 2024, 19, ⟨10.1371/journal.pone.0295700⟩. ⟨hal-04501283⟩
-
Florent Porquet, Lin Weidong, Kévin Jehasse, Hélène Gazon, Maria Kondili, et al.. Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells. Molecular Therapy - Nucleic Acids, 2023, 32, pp.857 - 871. ⟨10.1016/j.omtn.2023.05.007⟩. ⟨hal-04287597⟩
-
Caroline Le Guiner, T Larcher, A Lafoux, G Toumaniantz, S Webb, et al.. Characterization of the muscular and cardiac diseases of the DMSXL mouse model, a transgenic mouse model for Myotonic Dystrophy type 1. American Society of Gene & Cell Therapy, May 2023, LOS ANGELES, United States. ⟨hal-04096181⟩
-
Dylan Moutachi, Mégane Lemaitre, Clément Delacroix, Onnik Agbulut, Denis Furling, et al.. Valproic acid reduces muscle susceptibility to contraction‐induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophy. Clinical and Experimental Pharmacology and Physiology, In press, ⟨10.1111/1440-1681.13804⟩. ⟨hal-04146953⟩
Chiffres clés
132
Publications avec texte intégral
Open Access
52 %
Mots clés
Central nervous system
Duchenne muscular dystrophy
Humans
Thérapie génique
Cell culture model
Glucocorticoid-receptor
Oligodendrocytes
Therapy
DM1
Lc3
BIOLOGIE MOLECULAIRE
Mice
Myotonic Dystrophy
Myelin
Neuron
Heart failure
RNA interference
Glial cells
Heart
Acetylcholinesterase deficiency
Myotonic dystrophy
Expression
RNA biology
DMSXL mice
Dystrophie Myotonique
Cardiac muscle
CRISPR/Cas9
Myostatin
Transgenic mouse model
Autophagy
CTG repeat contractions
Intermediate filament
Dystrophin
DMPK
Centronuclear myopathy
Transcriptomics
Myotonic Dystrophy type 1
Transgenic mouse
Myotonic dystrophy type 1
CTG repeat instability
CMS
Mouse models
Antisense oligonucleotides
GSK3
PacBio
Motoneuron
Myotonic dystrophy mouse models
Dilated cardiomyopathy
CONGENITAL MYATHENIC SYNDROME
Mouse model
Cell penetrating peptide
KNOCKOUT MICE
Gene Therapy
CTG repeats
Trinucleotide Repeat Expansion
AAV
Glutamate
Animals
Gene therapy
RNA splicing
Exercice
Trinucleotide repeat expansion
Glucocorticoids
GABA
Brain dysfunction
Cell model
Desmin
In vivo
MBNL
Exercise
Acute coronary syndrome
Knockout
Hypoxia
Aging
Gene editing
Cytoskeleton
Myotonic Dystrophy Type 1
Long read sequencing
CRISPRi
Brain
Muscular dystrophy
Acetylcholinesterase knockout mouse
PCR
Oligodendrocyte
Genotype phenotype correlation
Antisense oligonucleotide
Maximal force
Astrocyte
Astrocytes
Muscle
Male
Quantitative microdialysis
Skeletal muscle
Dystrophie myotonique
ACETYLCHOLINESTERASE
Alternative splicing
ARN
Fibrosis
Diaphragm
Dynamin 2